Atlas Trials

AML96 - Risk-Adapted and Randomized Postremission-Therapy for Adult Acute Myeloid Leukemia Patients

Clinical trial NCT00180115 · COMPLETED

Trial details

NCT number
NCT00180115
Sponsor
Technische Universität Dresden
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Leukemia, Nonlymphoblastic, Acute
Start date
1996-02-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.